These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35613685)

  • 1. Development and Evaluation of Core-Shell Nanocarrier System for Enhancing the Cytotoxicity of Doxorubicin/Metformin Combination Against Breast Cancer Cell Line.
    Ibrahim A; Khalil IA; El-Sherbiny IM
    J Pharm Sci; 2022 Sep; 111(9):2581-2591. PubMed ID: 35613685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Layer-by-layer development of chitosan/alginate-based platelet-mimicking nanocapsules for augmenting doxorubicin cytotoxicity against breast cancer.
    Ibrahim A; Khalil IA; Mahmoud MY; Bakr AF; Ghoniem MG; Al-Farraj ES; El-Sherbiny IM
    Int J Biol Macromol; 2023 Jan; 225():503-517. PubMed ID: 36403763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using anti-PD-L1 antibody conjugated gold nanoshelled poly (Lactic-co-glycolic acid) nanocapsules loaded with doxorubicin: A theranostic agent for ultrasound imaging and photothermal/chemo combination therapy of triple negative breast cancer.
    Jiang H; Zhou Y; Zheng D; Cheng Y; Xiang D; Jiang L; Du J
    J Biomed Mater Res A; 2024 Mar; 112(3):402-420. PubMed ID: 37941485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles.
    Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Rahimi M; Akbarzadeh A; Zarghami N
    Pharm Res; 2018 Apr; 35(6):119. PubMed ID: 29671072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selol nanocapsules with a poly(methyl vinyl ether-co-maleic anhydride) shell conjugated to doxorubicin for combinatorial chemotherapy against murine breast adenocarcinoma in vivo.
    Ganassin R; Horst FH; Camargo NS; Chaves SB; Morais PC; Mosiniewicz-Szablewska E; Suchocki P; Figueiró Longo JP; Azevedo RB; Muehlmann LA
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1046-1052. PubMed ID: 29842818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
    Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-Assembled Monomethoxy (Polyethylene Glycol)-b-P(D,L-Lactic-co-Glycolic Acid)-b-P(L-Glutamic Acid) Hybrid-Core Nanoparticles for Intracellular pH-Triggered Release of Doxorubicin.
    Xu H; Cai C; Gou J; Sui B; Jin J; Xu H; Zhang Y; Wang L; Zhai Y; Tang X
    J Biomed Nanotechnol; 2015 Aug; 11(8):1354-69. PubMed ID: 26295138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers.
    Kucuksayan E; Bozkurt F; Yilmaz MT; Sircan-Kucuksayan A; Hanikoglu A; Ozben T
    Sci Rep; 2021 Jun; 11(1):13027. PubMed ID: 34158544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.
    Wang C; Sun X; Wang K; Wang Y; Yang F; Wang H
    Drug Deliv; 2016 Oct; 23(8):2697-2702. PubMed ID: 26203692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oily core/amphiphilic polymer shell nanocapsules change the intracellular fate of doxorubicin in breast cancer cells.
    Coelho JM; Camargo NS; Ganassin R; Rocha MCO; Merker C; Böttner J; Estrela-Lopis I; Py-Daniel KR; Jardim KV; Sousa MH; Ombredane AS; Joanitti GA; Silva RC; Azevedo RB; Longo JPF; Muehlmann LA
    J Mater Chem B; 2019 Oct; 7(41):6390-6398. PubMed ID: 31642844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
    Li JL; Zheng CL; Liu JP; Zhu JB
    Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
    Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
    J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLGA based particles as "drug reservoir" for antitumor drug delivery: characterization and cytotoxicity studies.
    Chronopoulou L; Domenici F; Giantulli S; Brasili F; D'Errico C; Tsaouli G; Tortorella E; Bordi F; Morrone S; Palocci C; Silvestri I
    Colloids Surf B Biointerfaces; 2019 Aug; 180():495-502. PubMed ID: 31103709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.
    Cao D; Zhang X; Akabar MD; Luo Y; Wu H; Ke X; Ci T
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):181-191. PubMed ID: 30686051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-Dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage.
    Siddharth S; Nayak A; Nayak D; Bindhani BK; Kundu CN
    Sci Rep; 2017 May; 7(1):2143. PubMed ID: 28526868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
    Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles.
    Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA
    Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.